Search Results

194,583 Results for "i mab".

Sort By

Layoffs

I-Mab Cuts 27% of Workforce After Pipeline Re-Prioritization

The layoffs follow an announcement in early January that I-Mab will re-prioritize resources to focus on advancing a CLDN18.2 and 4-1BB bispecific antibody for gastric cancers.

January 29, 2025
·
1 min read
·
Dan Samorodnitsky
Press Releases

I-Mab to Participate in Leerink Partners Global Healthcare Conference

February 18, 2025
·
1 min read
Press Releases

I-Mab to Present at Oppenheimer’s 35th Annual Healthcare Life Sciences Conference

February 4, 2025
·
1 min read
Business

I-Mab Appoints Phillip Dennis, MD, PhD, as Chief Medical Officer

I-Mab today announced the appointment of Dr. Phillip Dennis as Chief Medical Officer.

June 6, 2024
·
5 min read
Press Releases

I-Mab Announces Open Market Purchases of Company American Depositary Shares by Board Member

January 8, 2025
·
4 min read
Press Releases

I-Mab to Participate at the Piper Sandler Healthcare Conference

November 21, 2024
·
1 min read
Press Releases

I-Mab Reports Third Quarter 2024 Results

November 15, 2024
·
17 min read
BioCapital

I-Mab to Participate at the 2024 Jefferies Global Healthcare Conference

I-Mab, a U.S.-based global biotech company, exclusively focused on the development and potential commercialization of highly differentiated immunotherapies for the treatment of cancer, announced that management will present at the Jefferies Global Healthcare Conference on June 5, 2024.

May 22, 2024
·
1 min read
Press Releases

I-Mab to Participate at the Truist Securities BioPharma Symposium

October 28, 2024
·
1 min read
BioCapital

I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference

I-Mab announced that management will present at the 23rd Annual Needham Virtual Healthcare Conference on April 11, 2024.

April 5, 2024
·
1 min read